A detailed history of Primecap Management CO transactions in Medtronic PLC stock. As of the latest transaction made, Primecap Management CO holds 864,945 shares of MDT stock, worth $73.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
864,945
Previous 870,325 0.62%
Holding current value
$73.3 Million
Previous $68.5 Million 13.67%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$76.84 - $91.03 $413,399 - $489,741
-5,380 Reduced 0.62%
864,945 $77.9 Million
Q2 2024

Aug 09, 2024

SELL
$78.71 - $87.02 $539,163 - $596,087
-6,850 Reduced 0.78%
870,325 $68.5 Million
Q1 2024

May 13, 2024

BUY
$82.84 - $88.09 $39,763 - $42,283
480 Added 0.05%
877,175 $76.4 Million
Q4 2023

Feb 09, 2024

SELL
$69.43 - $83.43 $249,600 - $299,930
-3,595 Reduced 0.41%
876,695 $72.2 Million
Q3 2023

Nov 13, 2023

SELL
$78.22 - $90.4 $352,772 - $407,704
-4,510 Reduced 0.51%
880,290 $69 Million
Q2 2023

Aug 11, 2023

SELL
$79.47 - $91.38 $4.42 Million - $5.08 Million
-55,630 Reduced 5.92%
884,800 $78 Million
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $8.27 Million - $9.44 Million
-107,740 Reduced 10.28%
940,430 $75.8 Million
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $1.46 Million - $1.68 Million
-19,150 Reduced 1.79%
1,048,170 $81.5 Million
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $165,537 - $195,385
-2,050 Reduced 0.19%
1,067,320 $86.2 Million
Q2 2022

Aug 11, 2022

SELL
$87.4 - $113.09 $478,952 - $619,733
-5,480 Reduced 0.51%
1,069,370 $96 Million
Q1 2022

May 11, 2022

SELL
$100.58 - $112.38 $3.51 Million - $3.92 Million
-34,890 Reduced 3.14%
1,074,850 $119 Million
Q4 2021

Feb 11, 2022

SELL
$99.53 - $127.75 $855,958 - $1.1 Million
-8,600 Reduced 0.77%
1,109,740 $115 Million
Q3 2021

Nov 12, 2021

SELL
$122.75 - $135.17 $75.9 Million - $83.6 Million
-618,510 Reduced 35.61%
1,118,340 $140 Million
Q2 2021

Aug 10, 2021

SELL
$118.19 - $131.5 $48 Million - $53.5 Million
-406,510 Reduced 18.97%
1,736,850 $216 Million
Q1 2021

May 14, 2021

SELL
$111.18 - $119.74 $14 Million - $15.1 Million
-126,330 Reduced 5.57%
2,143,360 $253 Million
Q4 2020

Feb 08, 2021

SELL
$100.57 - $117.14 $20.4 Million - $23.7 Million
-202,390 Reduced 8.19%
2,269,690 $266 Million
Q3 2020

Nov 13, 2020

SELL
$90.13 - $108.78 $9.59 Million - $11.6 Million
-106,350 Reduced 4.12%
2,472,080 $257 Million
Q2 2020

Aug 13, 2020

SELL
$84.11 - $103.33 $6.76 Million - $8.3 Million
-80,340 Reduced 3.02%
2,578,430 $236 Million
Q1 2020

May 14, 2020

SELL
$72.92 - $121.3 $169 Million - $281 Million
-2,312,830 Reduced 46.52%
2,658,770 $240 Million
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $26.1 Million - $28.6 Million
-249,375 Reduced 4.78%
4,971,600 $564 Million
Q3 2019

Nov 13, 2019

SELL
$98.02 - $111.18 $118 Million - $134 Million
-1,206,550 Reduced 18.77%
5,220,975 $567 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $10.1 Million - $11.9 Million
-120,170 Reduced 1.84%
6,427,525 $626 Million
Q1 2019

May 14, 2019

SELL
$82.45 - $93.79 $56.6 Million - $64.4 Million
-687,080 Reduced 9.5%
6,547,695 $596 Million
Q4 2018

Feb 12, 2019

SELL
$85.8 - $99.49 $21.1 Million - $24.5 Million
-246,220 Reduced 3.29%
7,234,775 $658 Million
Q3 2018

Nov 13, 2018

SELL
$85.91 - $99.17 $58.6 Million - $67.6 Million
-681,957 Reduced 8.35%
7,480,995 $736 Million
Q2 2018

Aug 13, 2018

SELL
$77.48 - $87.83 $1.27 Million - $1.44 Million
-16,340 Reduced 0.2%
8,162,952 $699 Million
Q1 2018

May 14, 2018

SELL
$76.55 - $87.26 $43.9 Million - $50.1 Million
-573,806 Reduced 6.56%
8,179,292 $656 Million
Q4 2017

Feb 13, 2018

SELL
$76.93 - $83.5 $38.7 Million - $42 Million
-502,912 Reduced 5.43%
8,753,098 $707 Million
Q3 2017

Nov 13, 2017

BUY
$77.71 - $84.6 $719 Million - $783 Million
9,256,010
9,256,010 $720 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.